2025-08-20 - Analysis Report
Okay, here's the analysis of Eli Lilly and Co (LLY) based on the provided data, formatted for a report:

## Eli Lilly and Co (LLY) Stock Analysis

### 1. Performance vs. S&P 500 (VOO)

*   **Ticker:** LLY
*   **Company Description:** Eli Lilly and Co is a leading global pharmaceutical company.
*   **LLY Cumulative Return:** 210.20%
*   **VOO Cumulative Return:** 100.85%
*   **Absolute Divergence:** 107.8%
*   **Relative Divergence:** 37.7% (This places the current divergence at the 37.7th percentile of its historical range, meaning it's performing better than VOO but still in the lower range of historical outperformance.)

**Analysis:** LLY has significantly outperformed the S&P 500 (VOO) over the tracked period. However, the relative divergence suggests that while still positive, the degree of outperformance is not as high as it has been historically.

**Alpha/Beta Analysis**

| Year       | CAGR    | MDD    | Alpha  | Beta   | Cap(B) |
| ---------- | ------- | ------ | ------ | ------ | ------ |
| 2015-2017  | 10.0%   | 56.3%  | -19.0% | 0.0    | 76.3   |
| 2016-2018  | 39.0%   | 58.6%  | 21.0%  | -0.1   | 104.5  |
| 2017-2019  | 50.0%   | 58.6%  | 20.0%  | 0.3    | 118.7  |
| 2018-2020  | 52.0%   | 58.6%  | 33.0%  | 0.1    | 152.5  |
| 2019-2021  | 106.0%  | 60.6%  | 57.0%  | 0.2    | 249.4  |
| 2020-2022  | 98.0%   | 64.8%  | 96.0%  | 0.2    | 330.4  |
| 2021-2023  | 133.0%  | 64.8%  | 115.0% | 0.3    | 526.4  |
| 2022-2024  | 150.0%  | 72.2%  | 124.0% | 0.2    | 697.2  |
| 2023-2025  | 63.0%   | 76.8%  | 10.0%  | 0.2    | 630.4  |

*   **CAGR:** The Compound Annual Growth Rate shows strong growth, especially in recent years.  However, the 2023-2025 period shows a significant decrease, suggesting a possible deceleration in growth compared to the previous periods.
*   **MDD:** Maximum Drawdown indicates the potential downside risk. MDD is increasing through the years, indicating increased downside risk.
*   **Alpha:** A consistently positive Alpha indicates LLY is generating returns above what would be expected based on the market (S&P 500). The Alpha values are very high in recent periods, showing substantial outperformance. The 2023-2025 period is significantly lower than the rest.
*   **Beta:** A Beta close to zero indicates that LLY's price movements are not strongly correlated with the S&P 500.
*   **Cap(B):** The market capitalization has grown substantially over the years, reflecting the company's growth and investor confidence.

### 2. Recent Price Action

*   **Current Price:** 698.05
*   **Last Market Price:** 703.21
*   **Previous Close:** 698.05
*   **Change:** 0.74
*   **5-Day Moving Average:** 676.73
*   **20-Day Moving Average:** 729.68
*   **60-Day Moving Average:** 758.31

**Analysis:** The price increased slightly in the most recent session. The current price is below the 20-day and 60-day moving averages but above the 5-day moving average.  This suggests a potential short-term upward trend, but a longer-term downward trend is still in play.

### 3. Indicators and Signals

*   **Market Risk Indicator (MRI):** 0.329 (Low Risk)
*   **RSI:** 38.15 (Approaching oversold territory)
*   **PPO:** -0.397 (Negative, indicating a potential downtrend)
*   **Hybrid Signal:** Cash_69%_Sell 0.6% of holdings (1 shares - Caution - MRI:0.34)
*   **Delta Previous Relative Divergence:** -4.4 (Negative, indicating a recent short-term decline in relative performance)
*   **Expected Return:** 261.6% (Projected long-term outperformance vs. S&P 500)

**Analysis:** The low MRI suggests a relatively stable market environment for LLY. The RSI nearing oversold territory could indicate a potential buying opportunity. The negative PPO and Delta Relative Divergence suggest some short-term weakness.  The Hybrid Signal recommends a cautious approach, suggesting a slight reduction in holdings. The high expected return indicates strong long-term growth potential. The slight increase in the last market price may signal a short-term rebound.

### 4. Recent News & Events

*   **[2025-08-19] Major Business Developments, Regulatory Changes, or Market Events:** Requires further investigation to understand the impact.
*   **[2025-08-17] Analyst Discussions on Performance and Outlook:**  Important for understanding expert perspectives.
*   **[2025-08-16] Stock Volatility:** Requires monitoring to assess the cause and potential impact.
*   **[2025-08-18] Market Experts Highlight Risks and Opportunities:**  Important to consider both potential upsides and downsides.

**Analysis:** The news indicates that LLY is currently subject to significant market attention, potentially creating volatility. Investors should monitor these events closely.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출        |
| ---------- | ----- | ----------- |
| 2025-08-07 | 6.3   | 15.56 B$    |
| 2025-05-01 | 3.07  | 12.73 B$    |
| 2024-10-30 | 1.08  | 11.44 B$    |
| 2024-08-08 | 3.29  | 11.30 B$    |
| 2025-08-07 | 3.29  | 11.30 B$    |

**Analysis:** The recent earnings report (2025-08-07) shows a significant increase in both EPS and revenue compared to previous quarters. This is a positive signal for the company's performance.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
| ------------ | ---------- | --------------- |
| 2025-06-30   | $15.56B   | 84.27%          |
| 2025-03-31   | $12.73B   | 82.53%          |
| 2024-12-31   | $13.53B   | 82.24%          |
| 2024-09-30   | $11.44B   | 81.02%          |
| 2024-06-30   | $11.30B   | 80.80%          |

**Capital and Profitability:**

| Quarter      | Equity      | ROE      |
| ------------ | ----------- | -------- |
| 2025-06-30   | $18.27B    | 30.98%   |
| 2025-03-31   | $15.76B    | 17.50%   |
| 2024-12-31   | $14.19B    | 31.07%   |
| 2024-09-30   | $14.24B    | 6.81%    |
| 2024-06-30   | $13.56B    | 21.88%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue has been consistently increasing, and the profit margin is very high and also increasing. This indicates strong operational efficiency and pricing power.
*   **Capital and Profitability:** Equity has been growing, and the ROE fluctuates.

### 7. Overall Summary

Eli Lilly and Co (LLY) demonstrates strong historical outperformance relative to the S&P 500.  Recent earnings and financial data confirm continued robust growth in revenue and profitability. However, recent news suggests potential volatility. The technical indicators provide a mixed picture, with some short-term weakness signals but continued long-term growth potential. The hybrid signal suggests caution due to the current market dynamics.

**Recommendation:**

A long-term investment in LLY appears promising based on its strong financial performance and growth prospects. However, investors should closely monitor recent news and market volatility and consider a cautious approach in the short term.
